Celularity (CELUW) Common Equity (2018 - 2025)

Celularity (CELUW) has 8 years of Common Equity data on file, last reported at -$38.1 million in Q4 2025.

• Common Equity for Q4 2025 came in at -$38.1 million, down 530.71% year-over-year; the trailing twelve-month figure through Dec 2025 was -$38.1 million (down 530.71% YoY), and the FY2025 annual result was -$38.1 million, down 530.71% from the prior year.
• Common Equity retreated to -$38.1 million in Q4 2025 per CELUW's latest filing, from -$20.1 million in the prior quarter.
• Over five years, Common Equity peaked at $198.9 million in Q4 2022 and troughed at -$648.2 million in Q2 2021.
• A 5-year average of -$6.0 million and a median of $30.7 million in 2023 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2025: Common Equity soared 123.16% in 2022, then slumped 530.71% in 2025.
• A 5-year view of Common Equity shows it stood at $99.4 million in 2021, then jumped by 100.07% to $198.9 million in 2022, then tumbled by 79.41% to $41.0 million in 2023, then tumbled by 78.43% to $8.8 million in 2024, then tumbled by 530.71% to -$38.1 million in 2025.
• Business Quant data shows CELUW's Common Equity at -$38.1 million in Q4 2025, -$20.1 million in Q3 2025, and -$25.5 million in Q2 2025.